Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2013 (2013), Article ID 654218, 8 pages
http://dx.doi.org/10.1155/2013/654218
Clinical Study

Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study

1Nagoya Rheumatology Clinic/Initiative for Rheumatology and Osteoporosis, Nagoya 4500002, Japan
2Lilly Research Laboratories Japan, Eli Lilly Japan K.K., 7-1-5 Isogami dori, Chuoku, Kobe 6510086, Japan
3Statistical Programming, PharmaNet/i3 LLC, Indianapolis, IN 46280, USA
4Statistics, Eli Lilly and Company, Indianapolis, IN 46285, USA
5Surveillance & Epidemiology, Global Patient Safety Japan, Eli Lilly Japan K.K., Kobe 6510086, Japan
6Global Health Outcomes, Eli Lilly Australia Pty Ltd, Sydney 2114, Australia
7Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA

Received 5 August 2013; Accepted 25 October 2013

Academic Editor: Saeko Fujiwara

Copyright © 2013 Ikuko Tanaka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ikuko Tanaka, Masayo Sato, Tomoko Sugihara, et al., “Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study,” Journal of Osteoporosis, vol. 2013, Article ID 654218, 8 pages, 2013. doi:10.1155/2013/654218